RxDoctor Payments Data

Maria Daisy Ilano, MD

Psychiatry · Napa, CANPI 1083638100

Payments from drug & device makers

$2,352in general payments, 2019–2025

Across 119 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$598
  • AbbVie$377
  • Johnson & Johnson$274
  • Indivior Inc.$269
  • Otsuka America Pharmaceutical, Inc.$202
  • Alkermes, Inc.$196
  • plus $435 from 6 others

What the payments were for

  • Food & beverage$2,352100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,352 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$44,449
Medicare patients
113
Services billed
517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate15$117,835
Invega SustennaPaliperidone Palmitate29$71,004
VraylarCariprazine Hcl19$30,105
Lurasidone Hcl35$14,553
Aripiprazole138$12,376
Clomipramine Hcl34$9,220
Methylphenidate ErMethylphenidate Hcl14$3,695
Vilazodone Hcl28$3,086
Clozapine36$2,844
Quetiapine Fumarate64$2,145
Fluvoxamine Maleate15$2,099
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,864
Ziprasidone Hcl21$1,805
Temazepam65$1,693
Clonazepam165$1,506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$598$117,83515 claims
Johnson & JohnsonInvega Sustenna$274$71,00429 claims
AbbVieVraylar$377$30,10519 claims
Almatica Pharma LLCSertraline Hcl$28$481100 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Napa

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →